Evaluation of CCR2 in Patients Post Myocardial Infarction
NCT05107596
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Heart Diseases
Interventions
DRUG:
64Cu-DOTA-ECL1i
Sponsor
Washington University School of Medicine